Next generation DBS system for movement disorders receives Green Flag from FDA
The FDA recently approved Medtronic’s technologically advanced deep brain stimulation (DBS) system that has been designed to target motor symptoms in Parkinson’s disease, dystonia or essential tremor in a precise manner. The SenSight Directional Lead System for DBS therapy integrates the sensing capability that allows real-time monitoring of brain signals and a directional lead that […]